Clinical Trial Update: Predictive Value of Transcriptome-based OncoTreat/Oncotarget and Organoid Testing in Metastatic Pancreatic Cancer.

View source ↗

Summary

This clinical trial investigates whether transcriptome-based OncoTreat/Oncotarget profiling and patient-derived organoid testing can predict treatment response …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma
• Pancreatic Cancer

Snippet

Sponsor: Prof. Dr. med. Dres. h.c. Jan Schmidt, MME | Conditions: Pancreas Neoplasms, Pancreatic Neoplasms | Status: NOT_YET_RECRUITING